Sustained efficacy of secukinumab in patients with moderate-to-severe palmoplantar psoriasis: 2·5-year results from GESTURE, a randomized, double-blind, placebo-controlled trial

A B Gottlieb; A Kubanov; Martijn van Doorn; J Sullivan; KA Papp; R You; P Regnault; JA Frueh

doi:10.1111/bjd.18331

Sustained efficacy of secukinumab in patients with moderate-to-severe palmoplantar psoriasis: 2·5-year results from GESTURE, a randomized, double-blind, placebo-controlled trial

A B Gottlieb
, A Kubanov
, Martijn van Doorn
, J Sullivan
, KA Papp
, R You
, P Regnault
, JA Frueh

Dermatology

Research output: Contribution to journal › Article › Academic › peer-review

33 Citations (Scopus)

Original language	English
Pages (from-to)	889-899
Number of pages	11
Journal	British Journal of Dermatology
Volume	182
Issue number	4
DOIs	https://doi.org/10.1111/bjd.18331
Publication status	Published - 2020

Research programs

EMC OR-01

Access to Document

10.1111/bjd.18331

Cite this

Gottlieb, A. B., Kubanov, A., van Doorn, M., Sullivan, J., Papp, KA., You, R., Regnault, P., & Frueh, JA. (2020). Sustained efficacy of secukinumab in patients with moderate-to-severe palmoplantar psoriasis: 2·5-year results from GESTURE, a randomized, double-blind, placebo-controlled trial. British Journal of Dermatology, 182(4), 889-899. https://doi.org/10.1111/bjd.18331

@article{5152e2f8e3b4454abbffbed26affdd51,

title = "Sustained efficacy of secukinumab in patients with moderate-to-severe palmoplantar psoriasis: 2·5-year results from GESTURE, a randomized, double-blind, placebo-controlled trial",

author = "Gottlieb, \{A B\} and A Kubanov and \{van Doorn\}, Martijn and J Sullivan and KA Papp and R You and P Regnault and JA Frueh",

year = "2020",

doi = "10.1111/bjd.18331",

language = "English",

volume = "182",

pages = "889--899",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Oxford University Press",

number = "4",

}

Gottlieb, AB, Kubanov, A, van Doorn, M, Sullivan, J, Papp, KA, You, R, Regnault, P & Frueh, JA 2020, 'Sustained efficacy of secukinumab in patients with moderate-to-severe palmoplantar psoriasis: 2·5-year results from GESTURE, a randomized, double-blind, placebo-controlled trial', British Journal of Dermatology, vol. 182, no. 4, pp. 889-899. https://doi.org/10.1111/bjd.18331

Sustained efficacy of secukinumab in patients with moderate-to-severe palmoplantar psoriasis: 2·5-year results from GESTURE, a randomized, double-blind, placebo-controlled trial. / Gottlieb, A B; Kubanov, A; van Doorn, Martijn et al.
In: British Journal of Dermatology, Vol. 182, No. 4, 2020, p. 889-899.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Sustained efficacy of secukinumab in patients with moderate-to-severe palmoplantar psoriasis: 2·5-year results from GESTURE, a randomized, double-blind, placebo-controlled trial

AU - Gottlieb, A B

AU - Kubanov, A

AU - van Doorn, Martijn

AU - Sullivan, J

AU - Papp, KA

AU - You, R

AU - Regnault, P

AU - Frueh, JA

PY - 2020

Y1 - 2020

U2 - 10.1111/bjd.18331

DO - 10.1111/bjd.18331

M3 - Article

C2 - 31286480

SN - 0007-0963

VL - 182

SP - 889

EP - 899

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 4

ER -